[1]
2021. Efficacy and Safety of Crisaborole in Patients With Mild-to-Moderate Atopic Dermatitis With and Without Comorbid Allergic Rhinitis. SKIN The Journal of Cutaneous Medicine. 5, 1 (Jan. 2021), s13. DOI:https://doi.org/10.25251/skin.5.supp.13.